Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing

Establishing strong process characterization and validation early in development is critical for ensuring biologics are developed efficiently, remain compliant, and are ready to scale. However, these steps are often underestimated or delayed until later stages of development, which can increase risk and slow progress.

In this webinar, experts from Thermo Fisher Scientific share real-world case studies demonstrating how robust, data-driven process design can accelerate validation readiness and reduce manufacturing risk. The session highlights how an integrated approach to process understanding helps organizations move more quickly from development to commercial success. Through practical examples, the speakers also discuss strategies for achieving smooth technology transfer, designing and executing robust process characterization and validation, and effectively bridging development and commercial manufacturing using data-driven validation approaches — allowing biopharma innovators to reach validation readiness faster without compromising quality or compliance.